ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.
Von Eschenbach says oncology is undergoing a “revolutionary evolution.”
CCOPs ask NCI officials about one-year extensions.
Varmus: Why are scientific societies obstructing public access to research results?
Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says.
Onward to 2010? NCI promises faster progress for more money.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









